The DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics
Abstract
The NLR family pyrin domain containing 3 (NLRP3) inflammasome is responsible for the sensation of various pathogenic and non-pathogenic damage signals and has a vital role in neuroinflammation and neural diseases. Various stimuli, such as microbial infection, misfolded protein aggregates, and aberrant deposition of proteins can induce NLRP3 inflammasome in neural cells. Once triggered, the NLRP3 inflammasome leads to the activation of caspase-1, which in turn activates inflammatory cytokines, such as interleukin-1β and interleukin -18, and induces pyroptotic cell death. Mitochondria are critically involved in diverse cellular processes and are involved in regulating cellular redox status, calcium levels, inflammasome activation, and cell death. Mitochondrial dysfunction and subsequent accumulation of mitochondrial reactive oxygen species, mitochondrial deoxyribonucleic acid, and other mitochondria-associated proteins and lipids play vital roles in the instigation of the NLRP3 inflammasome. In addition, the processes of mitochondrial dynamics, such as fission and fusion, are essential in the maintenance of mitochondrial integrity and their imbalance also promotes NLRP3 inflammasome activation. In this connection, mitophagy-mediated maintenance of mitochondrial homeostasis restricts NLRP3 inflammasome hyperactivation and its consequences in various neurological disorders. Hence, mitophagy can be exploited as a potential strategy to target damaged mitochondria induced NLRP3 inflammasome activation and its lethal consequences. Therefore, the identification of novel mitophagy modulators has promising therapeutic potential for NLRP3 inflammasome-associated neuronal diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS increase with age due to mitochondrial dysfunction and inflammation, and can also drive NLRP3 inflammasome activation, likely further contributing to COVID-19 pathophysiology in the elderly58,76,77.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [77]
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2016) · Nature · doi:10.1038/nature18629 · Cited by 3,202
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Mechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282
The pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900
Cited by
Sorted by citations
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 975
SARS-CoV-2, COVID-19 and the aging immune system
Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359
Exploring the Role of Neuroplasticity in Development, Aging, and Neurodegeneration
Marzola, P., Melzer, T., Pavesi, E., Gil-Mohapel, J., & Brocardo, P. S. (2023) · Brain Sciences · doi:10.3390/brainsci13121610 · Cited by 281
Riegger, J., Schoppa, A., Ruths, L., Haffner‐Luntzer, M., & Ignatius, A. A. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00489-y · Cited by 261
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Liang, T., Zhang, Y., Wu, S., Chen, Q., & Wang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845185 · Cited by 226
Qiu, J., Chen, Y., Zhuo, J., Zhang, L., Liu, J., Wang, B., Sun, D., Yu, S., & Lou, H. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108963 · Cited by 175
Rehman, M. U., Sehar, N., Dar, N. J., Khan, A., Arafah, A., Rashid, S., Rashid, S. M., & Ganaie, M. A. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104961 · Cited by 130
Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagy
Luo, T., Jia, X., Feng, W.-D., Wang, J., Xie, F., Kong, L., Wang, X., Lian, R., Liu, X., Chu, Y.-J., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01094-7 · Cited by 140
Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy
Chen, Y., Shi, S., & Dai, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113903 · Cited by 125
Pu, X., Liu, J., Wang, Y., Guan, X., Wu, Q., Zhang, Q., Liu, R., & Chang, X. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.04.006 · Cited by 103
Xu, L., Yan, X., Zhao, Y., Song, J., Liu, B., Yu, S., Fu, J., Liu, Y., & Su, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169252 · Cited by 106
Feng, W., Zhang, Y., Xu, Z., Yu, S.-Y., Huo, J., Tuersun, A., Zheng, M., Zhao, J., Zong, Y., & Lu, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04187-3 · Cited by 88
Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis
Salnikova, D. I., Orekhova, V. A., Grechko, A. V., Starodubova, A. V., Bezsonov, E. E., Попкова, Т. В., & Orekhov, A. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168990 · Cited by 93
Pu, X., Zhang, Q., Liu, J., Wang, Y., Guan, X., Wu, Q., Liu, Z., Liu, Z., & Chang, X. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155880 · Cited by 87
Tang, C., Wang, Y., Chen, D., Zhang, M., Xu, J., Chen, X., Liu, J., Kan, J., & Jin, C. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113192 · Cited by 89
Role of mitochondria in physiological activities, diseases, and therapy
Wang, L., Zhou, X., & Lu, T. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00284-5 · Cited by 84
Immunosenescence and inflamm-ageing in COVID-19
Zinatizadeh, M. R., Zarandi, P. K., Ghiasi, M., Kooshki, H., Mohammadi, M., Amani, J., & Rezaei, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101818 · Cited by 69
Mitophagy in atherosclerosis: from mechanism to therapy
Zhang, Y., Weng, J., Huan, L., Sheng, S., & Xu, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1165507 · Cited by 67
Chiarini, A., Gui, L., Viviani, C., Armato, U., & Prà, I. D. (2023) · Biomedicines · doi:10.3390/biomedicines11040999 · Cited by 62
Huang, G., Zhang, Y., Zhang, Y., & Ma, Y. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101417 · Cited by 63
Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelae
Wei, X., Qian, W., Narasimhan, H., Chan, T., Liu, X., Arish, M., Young, S., Li, C., Cheon, I. S., Yu, Q., et al. (2025) · Science · doi:10.1126/science.adq2509 · Cited by 59
Zhang, X., Zeng, W., Zhang, Y., Yu, Q., Zeng, M., Gan, J., Zhang, W., Jiang, X., & Li, H. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5130 · Cited by 59
Chen, L., Mao, L., Xue, J.-Y., Jian, Y.-H., Deng, Z.-W., Mazhar, M., Zou, Y., Liu, P., Chen, M., Luo, G., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122998 · Cited by 59
Mitochondrial Dysfunction in Cardiac Arrhythmias
Deng, J., Jiang, Y., Chen, Z. B., Rhee, J., Deng, Y., & Wang, Z. V. (2023) · Cells · doi:10.3390/cells12050679 · Cited by 53
Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis
Xu, M., Wang, W., Cheng, J., Qu, H., Xu, M., & Wang, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116587 · Cited by 48
Huang, D., Chen, S., Xiong, D., Wang, H., Zhu, L., Wei, Y., Li, Y., & Zou, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0201 · Cited by 46
Chen, X., Zhou, Y., Wang, S., & Wang, W. (2021) · Inflammation · doi:10.1007/s10753-021-01569-x · Cited by 36
Liu, B., Wang, D., Cao, Y., Wu, J., Zhou, Y., Wu, W., Wu, J., Zhou, J., & Qiu, J. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175136 · Cited by 34
Ozone in the adjunct medical treatment. The round personality of a molecule with hormetic properties
Chirumbolo, S., Tirelli, U., Franzini, M., Pandolfi, S., Ricevuti, G., Vaiano, F., & Valdenassi, L. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271231218926 · Cited by 38
Rispoli, R. M., Popolo, A., Fabrizio, V. D., Bianca, R. D. D. V., Autore, G., Dalli, J., & Marzocco, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073072 · Cited by 34
The Impact of Pathogens on Sepsis Prevalence and Outcome
Dyck, B., Unterberg, M., Adamzik, M., & Koos, B. (2024) · Pathogens · doi:10.3390/pathogens13010089 · Cited by 35
Huang, C., Li, X., Li, H., Chen, R., Li, Z., Li, D., Xu, X., Zhang, G., Qin, L., Li, B., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05232-5 · Cited by 36
Ononin alleviates DSS‐induced colitis through inhibiting NLRP3 inflammasome via triggering mitophagy
Yu, T., Lu, X., Liang, Y., Yang, L., Yin, Y., & Chen, H. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.776 · Cited by 33
Targeting mitochondria in dermatological therapy: beyond oxidative damage and skin aging
Wikramanayake, T. C., Chéret, J., Sevilla, A., Birch‐Machin, M. A., & Paus, R. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2049756 · Cited by 31
Xue, M., Fu, M., Zhang, M., Xu, C., Meng, Y., Jiang, N., Li, Y., Liu, W., Fan, Y., & Zhou, Y. K. (2023) · Antioxidants · doi:10.3390/antiox12020306 · Cited by 31
Jia, M., Lv, X., Zhu, T., Shen, J.-C., Liu, W., & Yang, J. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06492-7 · Cited by 31
Fu, R., Tsai, C.-W., Chiu, S., Liu, S., Chiang, Y.-T., Kuo, Y.-H., Shyu, W., & Lin, S. (2022) · Cells · doi:10.3390/cells11193128 · Cited by 29
Irandoost, E., Najibi, S., Talebbeigi, S., & Nassiri, S. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02365-6 · Cited by 30
Hu, Q., Li, C., Zhang, T., Yi, L., Shan, Y., Ma, X., Cai, T., Li, R., Shen, H., & Li, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02263-1 · Cited by 30
Potential intervention target of atherosclerosis: Ferroptosis (Review)
Li, J., Xu, L., Zuo, Y., Chang, X., & Chi, H. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12859 · Cited by 28
Shadab, A., Abbasi‐Kolli, M., Saharkhiz, M., Ahadi, S. H., Shokouhi, B., & Nahand, J. S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116673 · Cited by 27
The landscape of mitophagy in sepsis reveals PHB1 as an NLRP3 inflammasome inhibitor
Chen, S., Ma, J., Yin, P., & Liang, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188482 · Cited by 26
Wu, W., Jia, H., Chen, S., Ma, X., Zhou, S. F., Qiu, L., Wu, X., Li, P., Chu, H., & Zhang, G. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00843-6 · Cited by 25
Mitochondrial dysfunction in diabetic neuropathy: Impaired mitophagy triggers NLRP3 inflammasome
Sriwastawa, K. K., & Kumar, A. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101972 · Cited by 26
Targeting inflammasomes as an immunotherapeutic strategy for cancer
Huang, L., Chen, X., Liu, R., Nan, D., Bao, W., Yang, L., Dai, X., Tang, J., Zhang, H., & Lu, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06665-2 · Cited by 23
Advances in Mitochondrial Dysfunction and Its Role in Cardiovascular Diseases
Qiu, Y. J., Chang, S., Zeng, Y., & Wang, X. (2025) · Cells · doi:10.3390/cells14201621 · Cited by 27
Wang, N., Zhang, X., Shen, P., Huang, C., Deng, H.-F., Zhou, L., Yue, L., Shen, B.-Y., Zhou, W., & Gao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.883865 · Cited by 24
Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
Lin, X., Wu, G., Wang, S., & Huang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1255158 · Cited by 47
Ayyubova, G., & Madhu, L. N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04758-z · Cited by 23
Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury
Jiang, W., He, F., Ding, G., & Wu, J. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14221 · Cited by 22
Chen, P., Wang, Y., Xie, J., Lei, J., & Zhou, B. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109950 · Cited by 20
PANoptosis in Sepsis: A Central Role and Emerging Therapeutic Target
Wu, Q., Qi, S., Kang, Z., Bai, X., Li, Z., Cheng, J., & Dong, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s513367 · Cited by 19
Roles and Mechanisms of NLRP3 in Influenza Viral Infection
Niu, J., & Meng, G. (2023) · Viruses · doi:10.3390/v15061339 · Cited by 21
Mishra, S. R., Behera, B. P., Singh, V. K., Mahapatra, K. K., Mundkinajeddu, D., Bhat, D., Minz, A. M., Sethi, G., Efferth, T., Das, S., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155157 · Cited by 18
Self-citationAlshahrani, M. Y., Jasim, S. A., Altalbawy, F. M. A., Bansal, P., Kaur, H., Al‐Hamdani, M. M., Deorari, M., Abosaoda, M. K., Hamzah, H. F., & Mohammed, B. A. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4029 · Cited by 19
Sharan, L., Pal, A., Babu, S., Kumar, A., & Banerjee, S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123203 · Cited by 18
Loh, D., & Reiter, R. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158122 · Cited by 17
NLRP3 inflammasome-mitochondrion loop in autism spectrum disorder
Vallese, A., Cordone, V., Ferrara, F., Guiotto, A., Gemmo, L., Cervellati, F., Hayek, J., Pecorelli, A., & Valacchi, G. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.10.297 · Cited by 16
Zhong, S., Shen, H., Dai, X., Liao, L., & Huang, C. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119226 · Cited by 16
Zhang, Z., Huang, T., Chen, X., Chen, J., Yuan, H., Yi, N., Miao, C., Sun, R., & Ni, S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115055 · Cited by 18
Tang, N., Wang, H., He, M., Geng, N., Zhao, X., Zhu, X., Yang, R., Gao, J., & Hang, C. (2026) · 3 Biotech · doi:10.1007/s13205-025-04691-x · Cited by 16
Liao, X., Wang, Y., Zhang, Z., Qu, X., & Zhou, G. (2026) · Mediators of Inflammation · doi:10.1155/mi/3168669 · Cited by 24
Wang, X., Xue, Y.-Q., Yao, Y., Li, Y., Ji, X., Chi, T., Liu, P., & Zou, L. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105298 · Cited by 17
Liang, S., Yang, Z., Hua, L., Chen, Y., Zhou, Y., Ou, Y., Chen, X., Hu, Y., Yang, X., Wu, X., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175156 · Cited by 16
Immunosenescence and Inflammaging in COVID-19
Asghari, F., Asghary, A., Zolbanin, N. M., Faraji, F., & Jafari, R. (2023) · Viral Immunology · doi:10.1089/vim.2023.0045 · Cited by 17
Zhang, Y.-T. Y., Guo, S., Fu, X., Zhang, Q., & Wang, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112342 · Cited by 16
Xiao, J., Huang, D., Wang, F., Gan, L., Zhang, W., Zhang, F., Tang, J., Shen, Z., Jiang, M., Egbobe, J. O., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115102 · Cited by 15
Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
Papantoniou, K., Aggeletopoulou, I., Michailides, C., Pastras, P., & Triantos, C. K. (2024) · Biology · doi:10.3390/biology13110945 · Cited by 15
Wang, J., Wu, M., Xiao, L., Du, G., Chen, M., Magupalli, V. G., Dahlberg, P. D., Wu, H., & Jensen, G. J. (2026) · Science Advances · doi:10.1126/sciadv.aee2473 · Cited by 16
Seifishahpar, M., Kalupahana, N. S., Kim, J. H., & Moustaïd‐Moussa, N. (2025) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-111224-024937 · Cited by 15
Pyroptosis-driven immune dysregulation in COPD: molecular mechanisms and therapeutic implications
Ni, F.-X., Wang, H., Hu, J., Chen, P., Huang, H.-J., Chen, H., Huang, D., & Jiang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1686175 · Cited by 14
Lee, J. Y., KANG, Y. Y., Jeon, J. Y., Kim, H. J., Kim, D. J., Lee, K. W., & Han, S. J. (2024) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2024.03.004 · Cited by 14
Mitophagy in Alzheimer's disease and its potential as a therapeutic target
Wei, J., Xiao, T., Lyu, J., Zhao, Y., Zhang, Y., Du, X., He, Y., Zhao, M., Yang, X., Yao, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107162 · Cited by 13
Lack of xanthine dehydrogenase leads to a remarkable renal decline in a novel hypouricemic rat model
Dissanayake, L. V., Zietara, A. P., Levchenko, V., Spires, D. R., Angulo, M. B., El‐Meanawy, A., Geurts, A. M., Dwinell, M. R., Palygin, O., & Staruschenko, A. (2022) · iScience · doi:10.1016/j.isci.2022.104887 · Cited by 15
An ROS-Responsive Antioxidative Macromolecular Prodrug of Caffeate for Uveitis Treatment
Li, Y., Sheng, S.-T., Yu, B., Jia, F., Wang, K., Han, H.-J., Jin, Q., Wang, Y., & Ji, J. (2022) · Chinese Journal of Polymer Science · doi:10.1007/s10118-022-2798-x · Cited by 12
Saha, S., Ray, S., Mandal, A., Das, U. B., Bhattacharya, T., Shireen, Z., Sarkar, S., Sharma, R. D., Ghosh, S., & Dey, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121911 · Cited by 12
Li, Y., Chen, W., & Feng, J. (2025) · Translational Stroke Research · doi:10.1007/s12975-025-01374-w · Cited by 11
Mishra, S. R., Mishra, P., Senapati, P. K., Mahapatra, K. K., & Bhutia, S. K. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189453 · Cited by 13
Self-citationLv, P., Chen, X., Liu, S., Zhang, Y., Bai, Y., Wang, S., & Wang, Y. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1636185 · Cited by 11
Gan, Y.-Q., Cai, Y.-W., Liang, X., Wang, L., Shi, F., Sun, N., Li, Y., Xu, R., Hu, B., Zha, Q., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1631152 · Cited by 11
Aedes aegypti saliva modulates inflammasome activation and facilitates flavivirus infection in vitro
Shrivastava, G., Leon, P. C. V., Botello, K., & Calvo, E. (2023) · iScience · doi:10.1016/j.isci.2023.108620 · Cited by 11
Inflammasome activation and accelerated immune aging in autoimmune disorders
Mittal, R., Saavedra, D., Mittal, M., Lemos, J. R. N., & Hirani, K. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1688060 · Cited by 13
Zhao, G., Wang, T., Luan, Y., Xu, Y., Qin, N., Chen, W., & Wang, Q. (2025) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203251351194 · Cited by 11
Fan, Y., Liu, X., Guan, F., Hang, X., He, X., & Jin, J. (2024) · Viruses · doi:10.3390/v16010100 · Cited by 11
Mitochondria in pyroptosis: Mechanisms and implications
Eldakhakhny, B. M., Abdulaal, W. H., Khan, J., Ajoolabady, A., Praticò, D., Bahijri, S., Tuomilehto, J. O., Borai, A., Kim, B., & Ren, J. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.12.002 · Cited by 9
Zhong, C., Yang, J., Deng, K., Lang, X., Zhang, J., Li, M., Qiu, L., Zhong, G., & Yu, J. (2023) · Molecules · doi:10.3390/molecules28227527 · Cited by 9
Kumari, M., Bisht, K. S., Ahuja, K., Motiani, R. K., & Maiti, T. K. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00057 · Cited by 14
Xiao, L., Liang, L., Zhou, S., Fan, P., & Yuan, C. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157486 · Cited by 8
Zhang, J., Chen, H., Wang, Y., Zhou, X., Zippi, M., Fiorino, S., Lin, W., & Hong, W. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02288-0 · Cited by 8
Crosstalk between myocardial autophagy and sterile inflammation in the development of heart failure
Tang, J., Tam, E., Song, E., Xu, A., & Sweeney, G. (2024) · Autophagy Reports · doi:10.1080/27694127.2024.2320605 · Cited by 8
Castillo, R. L., Farías, J. G., Sandoval, C., González‐Candia, A., Figueroa, E. G., Quezada, M., Cruz, G., Llanos, P., Jorquera, G., Sawa Kostin, D., et al. (2024) · Antioxidants · doi:10.3390/antiox13111388 · Cited by 10
Wada, Y., Umeno, R., Nagasu, H., Kondo, M., Tokuyama, A., Kadoya, H., Kidokoro, K., Taniguchi, S., Takahashi, M., Sasaki, T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179269 · Cited by 8
Khedpande, N., & Barve, K. H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04468-2 · Cited by 7
SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19
Aktar, S., & Amin, S. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198962 · Cited by 7
Dhasmana, S., Dhasmana, A., Kotnala, S., Mangtani, V., Narula, A. S., Haque, S., Jaggi, M., Yallapu, M. M., & Chauhan, S. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220915092703 · Cited by 7
Autophagy for secretory protein: Therapeutic targets in cancer
Mahapatra, K. K., Patra, S., Mishra, S. R., Behera, B. P., Patil, S., & Bhutia, S. K. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.009 · Cited by 7
Self-citationMitochondria as the central regulator of cell death in bronchopulmonary dysplasia
Zhang, F., Wang, L., & Zhou, Y. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1685526 · Cited by 6
Deng, L., Cai, T., Li, J., Song, Y., Guo, S., & Tao, T. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214507 · Cited by 6
Zhuang, W., Qu, M., Guan, Y., Pan, J., Tai, Y., Xie, G., Chen, X., & Zhu, F. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157505 · Cited by 6
Sekiya, F. S., da Silva, C. P. N., Oba‐Shinjo, S. M., Santos‐Bezerra, D. P., Ravagnani, F. G., Pasqualucci, C. A., Gil, S. D. S., Gualano, B., Baptista, M. S., Corrêa‐Giannella, M. L., et al. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111932 · Cited by 6
Metadata
- Authors
- Mishra, S. R., Mahapatra, K. K., Behera, B. P., Patra, S., Bhol, C. S., Panigrahi, D. P., Praharaj, P. P., Singh, A., Patil, S., Dhiman, R., & Bhutia, S. K.
- Affiliations
- National Institute of Technology Rourkela (IN)
- Jazan University (SA)
- Corresponding author
- Bhutia, Sujit Kumar
- ORCID
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 136
- Pages
- 106013
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W3161796677
- Semantic Scholar
- b4a92ba89affa9b84a67beeda34ec1a57be1bd99
- Cited by
- 195
- References
- 84
- Citations by year
- 2026: 51 · 2025: 47 · 2024: 37 · 2023: 27 · 2022: 29 · 2021: 4
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- The International Journal of Biochemistry & Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- NLRP3 inflammasome, mitochondrial dysfunction, mitophagy, neuroinflammation, pyroptosis, caspase-1, IL-1β, IL-18, mitochondrial dynamics, mitochondrial reactive oxygen species, mitochondrial DNA, mitochondrial homeostasis, neurodegenerative diseases
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Humans, Inflammation, Mitochondria, Mitochondrial Proteins, Inflammasomes, Mitochondrial Dynamics, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review